Supplemental Table 1 from Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome
Daniela Gasparotto(National Cancer Institute), Roberta Maestro(Centro di Riferimento Oncologico), Franco Stanzial(Ospedale di Bolzano), Angelo Paolo Dei Tos(University of Padua), Stefano Lamon(Ca' Foncello Hospital), Elisabetta Frate(Ca' Foncello Hospital), Marco Massani(AULSS 2 Marca Trevigiana), Sabrina Rossi(IRCCS Humanitas Research Hospital), R. Bracci(Ospedali Riuniti di Ancona), Jerin Agaj(Azienda Ospedaliera di Desio e Vimercate), Maurizio Polano(National Cancer Institute), Alessandro Gronchi(Fondazione IRCCS Istituto Nazionale dei Tumori), Marta Sbaraglia(University of Padua), Alessandra Mandolesi(Ospedali Riuniti di Ancona), Erica Lorenzetto(National Cancer Institute), Elena Tamborini(National Cancer Institute), Alessia Mondello(National Cancer Institute), Silvana Pilotti(Fondazione IRCCS Istituto Nazionale dei Tumori), Guido Mazzoleni
Cited by 0
Related Papers
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Isolation and <i>In vitro</i> Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties
|Cancer Research|2005|1.7k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k